KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Retained Earnings (2016 - 2026)

AbbVie has reported Retained Earnings over the past 14 years, most recently at -$1.1 billion for Q4 2025.

  • Quarterly Retained Earnings rose 40.57% to -$1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 billion through Dec 2025, up 40.57% year-over-year, with the annual reading at -$1.1 billion for FY2025, 40.57% up from the prior year.
  • Retained Earnings was -$1.1 billion for Q4 2025 at AbbVie, up from -$1.6 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $5.1 billion in Q1 2022 and troughed at -$9.5 billion in Q1 2025.
  • The 5-year median for Retained Earnings is -$2.3 billion (2023), against an average of -$1.5 billion.
  • Year-over-year, Retained Earnings crashed 374.79% in 2021 and then soared 265.02% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$2.9 billion in 2021, then soared by 265.02% to $4.8 billion in 2022, then crashed by 148.18% to -$2.3 billion in 2023, then increased by 16.49% to -$1.9 billion in 2024, then skyrocketed by 40.57% to -$1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Retained Earnings are -$1.1 billion (Q4 2025), -$1.6 billion (Q3 2025), and -$1.5 billion (Q2 2025).